Alignment Healthcare, Inc. (NASDAQ:ALHC) Receives Consensus Rating of “Moderate Buy” from Analysts

Alignment Healthcare, Inc. (NASDAQ:ALHC) has been given an average rating of “Moderate Buy” by the eleven brokerages that are presently covering the stock, MarketBeat reports. Four investment analysts have rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the company. The average 1-year price objective among brokerages that have issued ratings on the stock in the last year is $18.8333.

ALHC has been the topic of several research analyst reports. Wall Street Zen downgraded Alignment Healthcare from a “buy” rating to a “hold” rating in a research note on Sunday, August 10th. KeyCorp upgraded Alignment Healthcare from a “sector weight” rating to an “overweight” rating and set a $21.00 price target on the stock in a research note on Monday, August 25th. Stephens upgraded shares of Alignment Healthcare to a “strong-buy” rating in a report on Monday, June 2nd. Barclays raised shares of Alignment Healthcare from an “underweight” rating to an “equal weight” rating and increased their price objective for the company from $9.00 to $13.00 in a research report on Thursday, July 31st. Finally, Zacks Research raised shares of Alignment Healthcare to a “hold” rating in a research report on Friday, August 8th.

Insider Buying and Selling at Alignment Healthcare

In other news, insider Andreas P. Wagner sold 12,032 shares of the business’s stock in a transaction on Monday, August 25th. The shares were sold at an average price of $16.47, for a total transaction of $198,167.04. Following the sale, the insider directly owned 192,043 shares of the company’s stock, valued at $3,162,948.21. The trade was a 5.90% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, President Dawn Christine Maroney sold 30,000 shares of the company’s stock in a transaction on Monday, July 14th. The shares were sold at an average price of $13.44, for a total value of $403,200.00. Following the completion of the transaction, the president directly owned 2,042,899 shares in the company, valued at approximately $27,456,562.56. The trade was a 1.45% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 636,185 shares of company stock valued at $9,235,468. Company insiders own 7.00% of the company’s stock.

Institutional Investors Weigh In On Alignment Healthcare

A number of institutional investors and hedge funds have recently modified their holdings of the company. MCF Advisors LLC lifted its position in Alignment Healthcare by 87.6% during the first quarter. MCF Advisors LLC now owns 2,165 shares of the company’s stock valued at $40,000 after purchasing an additional 1,011 shares during the period. Skandinaviska Enskilda Banken AB publ purchased a new position in shares of Alignment Healthcare during the 1st quarter valued at about $42,000. SBI Securities Co. Ltd. lifted its holdings in shares of Alignment Healthcare by 4,868.9% in the 2nd quarter. SBI Securities Co. Ltd. now owns 3,031 shares of the company’s stock valued at $42,000 after buying an additional 2,970 shares during the period. KBC Group NV acquired a new position in shares of Alignment Healthcare in the 2nd quarter valued at about $44,000. Finally, Amalgamated Bank boosted its stake in shares of Alignment Healthcare by 21.6% in the first quarter. Amalgamated Bank now owns 3,466 shares of the company’s stock worth $65,000 after buying an additional 616 shares during the last quarter. Institutional investors and hedge funds own 86.19% of the company’s stock.

Alignment Healthcare Trading Down 2.7%

NASDAQ:ALHC opened at $15.86 on Friday. The stock has a market capitalization of $3.14 billion, a price-to-earnings ratio of -56.64 and a beta of 1.17. Alignment Healthcare has a 52 week low of $8.65 and a 52 week high of $21.06. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 2.29. The firm has a 50 day moving average of $14.18 and a 200 day moving average of $15.42.

Alignment Healthcare (NASDAQ:ALHC) last released its quarterly earnings results on Wednesday, July 30th. The company reported $0.07 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.07) by $0.14. The business had revenue of $1.02 billion for the quarter, compared to analyst estimates of $960.25 million. Alignment Healthcare had a negative net margin of 1.53% and a negative return on equity of 43.68%. The business’s revenue for the quarter was up 49.0% on a year-over-year basis. During the same period in the previous year, the company earned ($0.13) earnings per share. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. As a group, sell-side analysts anticipate that Alignment Healthcare will post -0.69 earnings per share for the current fiscal year.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.